{
    "nct_id": "NCT04341129",
    "official_title": "Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)",
    "inclusion_criteria": "* Women between the ages of 18-80.\n* Women with diagnostic imaging findings highly suspicious for breast cancer (BI-RADS category 4 or 5) or known breast cancer (BI-RADS category 6). Per BI-RADS lexicon, category 4 lesions carry a malignancy risk of 2-95% and category 5 lesions carry a malignancy risk of >95%.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years\nMust have maximum age of 80 Years",
    "exclusion_criteria": "* Women with a history of adverse reactions to contrast media.\n* Women with GFR below 30 mL/min/1.73m².",
    "miscellaneous_criteria": ""
}